Clinical Trial

Clinical Study of Allogeneic Fat Decellularized Active Protein in the Treatment of Pulmonary Fibrosis

Study acronym: CEFFE-PF
Active, Not Recruiting Early Phase 1
View on ClinicalTrials.gov →
Summary
The purpose of this clinical trial is to investigate the efficacy and safety of allogeneic adiphatic cyclic active protein in the treatment of pulmonary fibrosis. The main questions it aims to answer are: 1. Efficacy of allogeneic adiposeactive protein in the treatment of pulmonary fibrosis 2. Safety of allogeneic fat respiration active protein in the treatment of pulmonary fibrosis. A total of 7 participants will be enrolled. Participants will be asked that they will receive 2ml of each nebulized inhalation Cell Free Fat Extract (CEFFE), inhaled every 3 days, for a total of 7 nebulized inhalation treatments. The clinical trial was designed using a single-center, self-controlled trial with no control group and no blinding.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2023-05-22; most recent amendment 2025-09-15.
Status change: Recruiting → Active, Not Recruiting 2025-09-15
Trial Details
NCT Number NCT05883293
Lead Sponsor Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University
Conditions Pulmonary Fibrosis
Enrollment 7 participants
Start Date 2023-08-14
Primary Completion 2026-08-31 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2025-09-19